Morning Briefing
Summaries of health policy coverage from major news organizations
Push For Experimental Smallpox Drug Contract By Obama Administration Raises Questions, L.A. Times Reports
"Over the last year, the Obama administration has aggressively pushed a $433 million plan to buy an experimental smallpox drug, despite uncertainty over whether it is needed or will work," the Los Angeles Times reports. "Senior officials have taken unusual steps to secure the contract for New York-based Siga Technologies Inc., whose controlling shareholder is billionaire Ronald Perelman, one of the world's richest men and a longtime Democratic Party donor," including "replac[ed] the government's lead negotiator for the deal" and "blocked other firms from competing," the newspaper adds.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
